46.25
price up icon1.34%   0.61
after-market Handel nachbörslich: 46.20 -0.05 -0.11%
loading
Schlusskurs vom Vortag:
$45.64
Offen:
$45.31
24-Stunden-Volumen:
2.08M
Relative Volume:
0.96
Marktkapitalisierung:
$5.73B
Einnahmen:
$692.26M
Nettoeinkommen (Verlust:
$-512.41M
KGV:
-10.91
EPS:
-4.24
Netto-Cashflow:
$-274.36M
1W Leistung:
-3.83%
1M Leistung:
-5.88%
6M Leistung:
-2.01%
1J Leistung:
+44.53%
1-Tages-Spanne:
Value
$45.07
$46.43
1-Wochen-Bereich:
Value
$45.07
$49.30
52-Wochen-Spanne:
Value
$20.14
$53.42

Guardant Health Inc Stock (GH) Company Profile

Name
Firmenname
Guardant Health Inc
Name
Telefon
855-698-8887
Name
Adresse
3100 HANOVER STREET, PALO ALTO
Name
Mitarbeiter
2,021
Name
Twitter
@guardanthealth
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
GH's Discussions on Twitter

Vergleichen Sie GH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
GH
Guardant Health Inc
46.25 5.96B 692.26M -512.41M -274.36M -4.24
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
427.62 157.79B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
189.91 138.02B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
532.00 42.36B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
116.19 32.08B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
187.38 27.28B 15.50B 1.33B 2.16B 7.34

Guardant Health Inc Stock (GH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-10 Eingeleitet Mizuho Outperform
2025-01-23 Eingeleitet Barclays Overweight
2024-06-28 Hochstufung Guggenheim Neutral → Buy
2024-06-03 Fortgesetzt Jefferies Buy
2024-04-24 Fortgesetzt Craig Hallum Buy
2023-12-14 Eingeleitet Guggenheim Neutral
2023-12-13 Eingeleitet Wolfe Research Peer Perform
2023-11-13 Hochstufung Raymond James Mkt Perform → Outperform
2023-09-28 Eingeleitet Bernstein Outperform
2023-09-27 Hochstufung Piper Sandler Neutral → Overweight
2023-07-05 Fortgesetzt JP Morgan Overweight
2023-05-26 Hochstufung Citigroup Neutral → Buy
2023-05-05 Eingeleitet UBS Buy
2023-03-09 Herabstufung Citigroup Buy → Neutral
2023-01-05 Eingeleitet Scotiabank Sector Outperform
2022-11-01 Herabstufung Piper Sandler Overweight → Neutral
2022-10-19 Eingeleitet Craig Hallum Buy
2022-10-06 Eingeleitet Stephens Overweight
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-06-03 Eingeleitet Piper Sandler Overweight
2022-04-28 Fortgesetzt BTIG Research Buy
2022-02-24 Bestätigt Canaccord Genuity Buy
2022-02-24 Bestätigt Citigroup Buy
2022-02-24 Bestätigt Cowen Outperform
2022-02-24 Bestätigt Morgan Stanley Overweight
2022-02-24 Bestätigt SVB Leerink Outperform
2022-02-24 Bestätigt Stifel Buy
2022-02-24 Bestätigt Wells Fargo Overweight
2021-10-15 Fortgesetzt Cowen Outperform
2021-06-15 Eingeleitet Raymond James Mkt Perform
2021-06-03 Eingeleitet Goldman Buy
2021-05-25 Eingeleitet Wells Fargo Overweight
2021-01-11 Eingeleitet Stifel Buy
2020-09-09 Eingeleitet Morgan Stanley Overweight
2020-06-12 Eingeleitet BTIG Research Buy
2020-02-21 Eingeleitet Guggenheim Buy
2020-01-07 Eingeleitet Citigroup Buy
2019-08-07 Bestätigt Canaccord Genuity Buy
2019-04-16 Eingeleitet Canaccord Genuity Buy
2019-04-10 Hochstufung BofA/Merrill Neutral → Buy
2019-02-28 Bestätigt BofA/Merrill Neutral
2018-10-29 Eingeleitet BofA/Merrill Neutral
2018-10-29 Eingeleitet JP Morgan Overweight
2018-10-29 Eingeleitet William Blair Outperform
Alle ansehen

Guardant Health Inc Aktie (GH) Neueste Nachrichten

pulisher
Jul 22, 2025

Guardant Health Inc. Stock Analysis and ForecastFree Capital Allocation Plans - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Guardant Health Inc. a good long term investmentFree Consultation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Cathie Wood’s ARK ETFs shift focus, buying NVIDIA and selling GUARDANT - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Guardant Health Inc. stockConsistently superior profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Guardant Health Inc. stock priceExplosive wealth accumulation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Freenome's new CEO is ready to compete in race for tests that can detect cancer earlySan Francisco Business Times - The Business Journals

Jul 21, 2025
pulisher
Jul 19, 2025

Cathie Wood's Ark Invest Offloads Meta, Loads Up On Teradyne, Caris Life Sciences - Benzinga

Jul 19, 2025
pulisher
Jul 18, 2025

Guardant Health (GH): director Tariq Musa sells $5591 in stock By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

Guardant Health (GH): director Tariq Musa sells $5591 in stock - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Guardant Health Director Sells 142 Shares at $48.2 Per Share on 2025-07-17. - AInvest

Jul 18, 2025
pulisher
Jul 16, 2025

Global Liquid Biopsy Market Size Worth USD 25.24 Billion By 2032 | - openPR.com

Jul 16, 2025
pulisher
Jul 16, 2025

Lung Cancer Diagnostics Market Expansion Driven by Liquid - openPR.com

Jul 16, 2025
pulisher
Jul 16, 2025

(GH) Technical Data - news.stocktradersdaily.com

Jul 16, 2025
pulisher
Jul 15, 2025

User - FinancialContent

Jul 15, 2025
pulisher
Jul 15, 2025

Evercore ISI Keeps Their Buy Rating on Guardant Health (GH) - The Globe and Mail

Jul 15, 2025
pulisher
Jul 15, 2025

Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025 - BioSpace

Jul 15, 2025
pulisher
Jul 14, 2025

Guardant Health stock price target maintained at $60 by Evercore ISI - Investing.com Canada

Jul 14, 2025
pulisher
Jul 14, 2025

What makes Guardant Health Inc. stock price move sharplyFree Stock Portfolio Optimization - beatles.ru

Jul 14, 2025
pulisher
Jul 14, 2025

Press Release: Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025 - 富途牛牛

Jul 14, 2025
pulisher
Jul 11, 2025

Quinn Emanuel Sanctioned For Ad Case 'Misrepresentations' - Law360

Jul 11, 2025
pulisher
Jul 11, 2025

Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

US judge rebukes law firm Quinn Emanuel, awards $3 million sanction in Guardant case - Reuters

Jul 11, 2025
pulisher
Jul 10, 2025

East Bay company looks to bring cancer insights to rheumatoid arthritisSan Francisco Business Times - The Business Journals

Jul 10, 2025
pulisher
Jul 08, 2025

Precision Medicine Market worth $246.66 billion by 2029 with 11.1% CAGRRIVER COUNTRY - RIVER COUNTRY - NEWS CHANNEL NEBRASKA

Jul 08, 2025
pulisher
Jul 03, 2025

Guardant Health Insider Sold Shares Worth $5,087,630, According to a Recent SEC Filing - MarketScreener

Jul 03, 2025
pulisher
Jun 30, 2025

The 5 Most Interesting Analyst Questions From Guardant Health’s Q1 Earnings Call - Yahoo Finance

Jun 30, 2025
pulisher
Jun 27, 2025

Is GH's Q1 2025 forecast achievable? - AInvest

Jun 27, 2025
pulisher
Jun 27, 2025

Exas, Guardant, Gilead among gainers as Supreme Court ensures free preventive care - MSN

Jun 27, 2025
pulisher
Jun 27, 2025

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer - The Lancet

Jun 27, 2025
pulisher
Jun 27, 2025

Guardant Health’s Colorectal Cancer Screening Test Earns Another Honor - Medical Product Outsourcing

Jun 27, 2025
pulisher
Jun 26, 2025

Precision Medicine: The Future of Healthcare? Companies Like Tempus AI, Guardant Health, and Exact Sciences Are Pioneering the Way - AInvest

Jun 26, 2025
pulisher
Jun 25, 2025

Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out - Benzinga

Jun 25, 2025
pulisher
Jun 24, 2025

Guardant Health gets Breakthrough Device Designation from FDA for cancer detection test - Mugglehead Magazine

Jun 24, 2025
pulisher
Jun 23, 2025

Medical Services Stock Near A Buy Point, It Just Needs A Boost - Investor's Business Daily

Jun 23, 2025
pulisher
Jun 20, 2025

Guardant Health Elects Board and Approves Auditor - TipRanks

Jun 20, 2025
pulisher
Jun 19, 2025

Guardant Health, Inc. (NASDAQ:GH) Looks Just Right With A 26% Price Jump - simplywall.st

Jun 19, 2025
pulisher
Jun 18, 2025

Guardant Health’s Multi-Cancer Detection Test Wins FDA Breakthrough Designation - Medical Product Outsourcing

Jun 18, 2025
pulisher
Jun 17, 2025

Australian biotech uncovers broader view of tumour genetics with liquid biopsy - Mugglehead Magazine

Jun 17, 2025
pulisher
Jun 17, 2025

Guardant Health director sells shares worth $157,573 By Investing.com - Investing.com UK

Jun 17, 2025
pulisher
Jun 16, 2025

Insider Sell: Meghan Joyce Sells Shares of Guardant Health Inc (GH) - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Guardant Health director sells shares worth $157,573 - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

Guardant Health Executives Sell Shares - TradingView

Jun 16, 2025
pulisher
Jun 16, 2025

Guardant Health up 4% on Q1 beats, 2025 guidance revenue raise - MSN

Jun 16, 2025
pulisher
Jun 16, 2025

Non-Invasive Cancer Testing Market Forecast | Major Players: Guardant Health, Exact Sciences, Qiagen, Natera Inc. - openPR.com

Jun 16, 2025

Finanzdaten der Guardant Health Inc-Aktie (GH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research WAT
$287.46
price up icon 2.06%
$139.92
price down icon 0.50%
diagnostics_research DGX
$178.24
price up icon 7.08%
diagnostics_research LH
$252.07
price up icon 3.72%
diagnostics_research MTD
$1,218.96
price up icon 4.50%
diagnostics_research IQV
$187.38
price up icon 17.88%
Kapitalisierung:     |  Volumen (24h):